Literature DB >> 25712542

Polyneuritis cranialis: oculopharyngeal subtype of Guillain-Barré syndrome.

Benjamin R Wakerley1,2, Nobuhiro Yuki3.   

Abstract

Guillain-Barré syndrome (GBS) constitutes a spectrum of related post-infectious neuropathies, which are characterized by their anatomical patterns of weakness and neurological involvement. Historically, the term polyneuritis cranialis has been used to describe some patients with GBS presenting with multiple cranial neuropathies in the absence of limb weakness. We examine previous reports of polyneuritis cranialis to determine disease characteristics and define new diagnostic criteria. Disease characteristics were determined from 15 historical case reports of patients presenting with isolated 'polyneuritis cranialis', 'cranial polyneuropathy', 'multiple cranial neuropathy' and 'multiple cranial neuropathies' due to GBS. Median age was 40 years. 80% displayed antecedent infectious symptoms. In all cases, disease course was monophasic with clinical improvement within weeks or months. Initial symptoms were ocular (73%) or bulbar (33%). Mean number of cranial nerves involved was 6 (range, 3-10). 93% displayed ocular signs, 73% facial weakness or numbness and 87% bulbar signs. In 3 patients (20%), there was significant asymmetry. Cerebrospinal fluid albuminocytological dissociation was present in 67% of cases. Serum anti-ganglioside antibodies were tested for in 8 of 15 patients and anti-GQ1b antibodies were found in 3 patients, whilst anti-GT1a antibodies were found in 1 patient. Polycranial neuritis (the oculopharyngeal subtype of GBS) can be defined in patients with disease characteristics of GBS who display ocular and pharyngeal weakness in the absence of limb weakness or ataxia. In half of cases tested for, anti-ganglioside antibodies were present and most frequently against GQ1b.

Entities:  

Keywords:  Acute ophthalmoparesis; Cranial polyneuropathy; Guillain-Barré syndrome; Miller Fisher syndrome; Pharyngeal-cervical-brachial weakness; Polyneuritis cranialis

Mesh:

Year:  2015        PMID: 25712542     DOI: 10.1007/s00415-015-7678-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  55 in total

1.  RELATION OF MULTIPLE CRANIAL NERVE DYSFUNCTION TO THE GUILLAIN-BARR'E SYNDROME.

Authors:  T L MUNSAT; J E BARNES
Journal:  J Neurol Neurosurg Psychiatry       Date:  1965-04       Impact factor: 10.154

2.  Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome.

Authors:  A Chiba; S Kusunoki; T Shimizu; I Kanazawa
Journal:  Ann Neurol       Date:  1992-06       Impact factor: 10.422

3.  Polyneuritis cranialis as the sole manifestation of the Guillain-Barré syndrome.

Authors:  H R McFarland
Journal:  Mo Med       Date:  1976-05

4.  Non-demyelinating, reversible conduction failure in Fisher syndrome and related disorders.

Authors:  Thirugnanam Umapathi; Eyok Yian Tan; Norito Kokubun; Kamal Verma; Nobuhiro Yuki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-07-05       Impact factor: 10.154

5.  Isolated abducens nerve palsy as a regional variant of Guillain-Barré syndrome.

Authors:  Muneto Tatsumoto; Masaaki Odaka; Koichi Hirata; Nobuhiro Yuki
Journal:  J Neurol Sci       Date:  2006-01-05       Impact factor: 3.181

6.  Acute multiple cranial neuropathy: a variant of Guillain-Barré syndrome?

Authors:  Rong-Kuo Lyu; Sien-Tsong Chen
Journal:  Muscle Nerve       Date:  2004-10       Impact factor: 3.217

7.  Polyneuritis cranialis presenting with anti-GQ1b IgG antibody.

Authors:  Bengt Edvardsson; Staffan Persson
Journal:  J Neurol Sci       Date:  2009-03-25       Impact factor: 3.181

8.  Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies.

Authors:  A Chiba; S Kusunoki; H Obata; R Machinami; I Kanazawa
Journal:  Neurology       Date:  1993-10       Impact factor: 9.910

9.  Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles.

Authors:  Jing-Xia Liu; Hugh J Willison; Fatima Pedrosa-Domellöf
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-28       Impact factor: 4.799

Review 10.  Mimics and chameleons in Guillain-Barré and Miller Fisher syndromes.

Authors:  Benjamin R Wakerley; Nobuhiro Yuki
Journal:  Pract Neurol       Date:  2014-09-19
View more
  7 in total

1.  Bilateral Sixth Nerve Palsy and Nasal Voice in Two Sisters as a Variant of Guillan-Barré Syndrome.

Authors:  Francesco Pellegrini; Margaret Wang; Napoleone Romeo; Andrew G Lee
Journal:  Neuroophthalmology       Date:  2018-01-11

2.  Polyneuritis cranialis--subtype of Guillain-Barré syndrome?

Authors:  Benjamin R Wakerley; Nobuhiro Yuki
Journal:  Nat Rev Neurol       Date:  2015-09-15       Impact factor: 42.937

3.  Guillain-Barré syndrome variant with facial diplegia and paresthesias after reactivation of varicella zoster virus.

Authors:  Xiaodong Chen; Ying Wang; Yongjun Cao
Journal:  Neurol Sci       Date:  2017-05-16       Impact factor: 3.830

4.  Clinical Heterogeneity of Anti-GM2-Ganglioside-Antibody Syndrome.

Authors:  Jong Kuk Kim; Yoo Hwan Kim; Byeol A Yoon; Joong Yang Cho; Sun Young Oh; Ha Young Shin; Ji Soo Kim; Kee Hong Park; Sun Young Kim; Bum Chun Suh; Hung Youl Seok; Jin Hyuk Yoo; Jong Seok Bae
Journal:  J Clin Neurol       Date:  2018-07       Impact factor: 3.077

5.  An Oculopharyngeal Subtype of Guillain-Barré Syndrome Sparing the Trochlear and Abducens Nerves.

Authors:  Masafumi Arakawa; Mineo Yamazaki; Yusuke Toda; Akiko Ozawa; Kazumi Kimura
Journal:  Intern Med       Date:  2020-02-05       Impact factor: 1.271

6.  Case Report: Acute Bulbar Palsy Plus Syndrome: A Guillain-Barré Syndrome Variant More Prone to Be a Subtype Than Overlap of Distinct Subtypes.

Authors:  Qian Cao; Hong Chu; Xiujuan Fu; Jiajia Yao; Zheman Xiao; Zuneng Lu
Journal:  Front Neurol       Date:  2020-11-24       Impact factor: 4.003

7.  Polyneuritis Cranialis Associated with BNT162b2 mRNA COVID-19 Vaccine in a Healthy Adolescent.

Authors:  Pimchanok Kulsirichawaroj; Oranee Sanmaneechai; Orasri Wittawatmongkol; Kulkanya Chokephaibulkit
Journal:  Vaccines (Basel)       Date:  2022-01-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.